Produção Nacional
Revisado por pares
... coração situam algumas cidades brasileiras na posição intermediária (Hungria, Rio de Janeiro, Finlândia, Porto Alegre e Polônia) ... as mulheres no topo (Rio de Janeiro, Curitiba, Hungria, Porto Alegre, Inglaterra e Gales); b) DC apresentou ... das doenças do coração entre os homens (Finlândia, Hungria, Inglaterra e Gales, Porto Alegre e Rio de ... das doenças do coração (Rio de Janeiro, Curitiba, Hungria, Porto Alegre, Inglaterra e Gales). CONCLUSÃO: A comparação ...
Tópico(s): Maternal and Neonatal Healthcare
1998 - Sociedade Brasileira de Cardiologia (SBC) | Arquivos Brasileiros de Cardiologia
Produção Nacional
Revisado por pares
Edison Noboru Fujiki, Sérgio S Kuwajima, Emerson Kiyoshi Honda, Carlo Milani, Luiz Carlos K Porto, Takeshi Chikude, Walter Yoshinori Fukushima, Nelson Ono,
... an osteotomy that is a modification of the Hungria-Kramer intertrochanteric osteotomy proposed by Sugioka (Hungria-Kramer-Sugioka osteotomy or HKS osteotomy). The degree ...
Tópico(s): Cardiac Valve Diseases and Treatments
2005 - Lippincott Williams & Wilkins | Journal of Pediatric Orthopaedics
Produção Nacional
Revisado por pares
Dominik Dytfeld, Binod Dhakal, Mounzer Agha, Salomon Manier, Michel Delforge, Steven Kuppens, Salma Afifi, William Deraedt, Agne Taraseviciute-Morris, Jordan M. Schecter, Jane Gilbert, Fevzi Yalniz, Erika Florendo, Lida Pacaud, Vânia Hungria, Saad Z. Usmani, María‐Victoria Mateos,
... Biotech: Current Employment. Pacaud: Legend Biotech: Current Employment. Hungria: Abbvie: Honoraria; Takeda: Honoraria; Sanofi: Honoraria, Other: Support ...
Tópico(s): Multiple Myeloma Research and Treatments
2021 - Elsevier BV | Blood
Produção Nacional
Revisado por pares
Shaji Kumar, Simon J. Harrison, Michèle Cavo, Javier de la Rubia, Rakesh Popat, Cristina Gasparetto, Vânia Hungria, Hans Salwender, Kenshi Suzuki, Inho Kim, Maika Onishi, Grace Ku, Rajvineeth Kumar Pothacamury, Vasudha Sehgal, Abdullah Al Masud, Jeremy A. Ross, Edyta Dobkowska, Philippe Moreau,
... Other: TRAVEL, ACCOMMODATIONS, EXPENSES, Research Funding, Speakers Bureau. Hungria: Sanofi: Honoraria, Other: Support for attending meetings/travel ; ...
Tópico(s): Cancer Mechanisms and Therapy
2021 - Elsevier BV | Blood
Produção Nacional
Revisado por pares
Katja Weisel, Pieter Sonneveld, María‐Victoria Mateos, Vânia Hungria, Andrew Spencer, Jane Estell, Wolney Barreto, Paolo Corradini, Chang‐Ki Min, Eva Medvedova, Maria Krevvata, Sonali Trivedi, Xiang Qin, Huiling Pei, Jon Ukropec, Rachel Kobos, Ming Qi, Ajay K. Nooka,
... entity's Board of Directors or advisory committees. Hungria:BMS: Consultancy, Honoraria, Speakers Bureau; Janssen: Consultancy, Honoraria, ...
Tópico(s): Cancer Mechanisms and Therapy
2019 - Elsevier BV | Blood
Produção Nacional
Revisado por pares
Vânia Hungria, Hans C. Lee, Rafat Abonour, Robert M. Rifkin, Evangelos Terpos, Xavier Leleu, Caitlin Costello, Frits van Rhee, Katja Weisel, Noemí Puig, Jesús G. Berdeja, Gordon Cook, Saad Z. Usmani, Michael A. Thompson, Mario Boccadoro, Jeffrey A. Zonder, Andrew Spencer, Roman Hájek, Suzanne Fanning, Kevin Boyd, Jim Omel, Mira Armour, Kathryn E. Morgan, Ronak S. Patel, Gary L. Carlson, Renda H. Ferrari, Dawn Marie Stull, Kaili Ren, Dasha Cherepanov, James V. Pottala, Ajai Chari,
... to broaden oncology clinical trial eligibility criteria. Disclosures Hungria: Abbvie: Consultancy, Membership on an entity's Board ...
Tópico(s): Peptidase Inhibition and Analysis
2019 - Elsevier BV | Blood
Produção Nacional
Revisado por pares
Philippe Moreau, Simon J. Harrison, Michèle Cavo, Javier de la Rubia, Rakesh Popat, Cristina Gasparetto, Vânia Hungria, Hans Salwender, Kenshi Suzuki, Inho Kim, Francesca Gay, Gábor Mikala, Elizabeth A. Punnoose, Wan‐Jen Hong, Anjla Sood, Muhammad Jalaluddin, Jeremy A. Ross, James E. Ward, Paulo Maciag, Shaji Kumar,
... Travel, accommodations, or other expenses paid or reimbursed . Hungria:Celgene: Consultancy, Honoraria, Membership on an entity's ...
Tópico(s): Cancer Mechanisms and Therapy
2019 - Elsevier BV | Blood
Produção Nacional
Revisado por pares
Simon J. Harrison, Michèle Cavo, Javier de la Rubia, Rakesh Popat, Cristina Gasparetto, Vânia Hungria, Hans Salwender, Kenshi Suzuki, Inho Kim, Philippe Moreau, Andrew Spencer, Michael O’Dwyer, Mamta Garg, Elizabeth A. Punnoose, Muhammad Jalaluddin, Jia Jia, Xiaoqing Yang, Yan Sun, James E. Ward, Paulo Maciag, Jeremy A. Ross, Shaji Kumar,
... Travel, accommodations, or other expenses paid or reimbursed . Hungria:Celgene: Consultancy, Honoraria, Membership on an entity's ...
Tópico(s): Cancer Mechanisms and Therapy
2019 - Elsevier BV | Blood
Produção Nacional
Revisado por pares
Meletios Α. Dimopoulos, Sara Bringhen, Pekka Anttila, Marcelo Capra, Michèle Cavo, Craig E. Cole, Cristina Gasparetto, Vânia T. M. Hungria, Matthew Jenner, Vladimir Vorobyev, Eduardo Yañez Ruiz, Jianyun Yin, Anthony Hamlett, Ravi Vij,
... Myers Squibb: Consultancy, Honoraria, Other: Travel; Takeda: Honoraria. Hungria:Janssen: Honoraria; Celgene: Honoraria; Amgen: Honoraria; Takeda: Honoraria. ...
Tópico(s): Cancer Mechanisms and Therapy
2018 - Elsevier BV | Blood
Produção Nacional
Revisado por pares
Andrew Spencer, Vânia Hungria, María‐Victoria Mateos, Ajay K. Nooka, Jane Estell, Wolney Barreto, Paolo Corradini, Chang‐Ki Min, Eva Medvedova, Piruntha Thiyagarajah, William Deraedt, Christopher Chiu, Jordan M. Schecter, Katja Weisel,
... Honoraria, Research Funding; Amgen: Consultancy, Honoraria, Research Funding. Hungria: Celgene, Roche, Takeda, Janssen, Amgen: Honoraria. Mateos: Amgen: ...
Tópico(s): Protein Degradation and Inhibitors
2017 - Elsevier BV | Blood
... ha hecho publico el caso del presidente de Hungria, Pal Schmitt, a quien la Semmelweis University de ... la dimision de Schmitt a la presidencia de Hungria, el 2 de abril de 2012. Estos casos ...
Tópico(s): Academic integrity and plagiarism
2013 - Pontificia Universidad Catolica de Chile | Revista Chilena de Derecho
Diogo Costa, Joaquim Soares, Jutta Lindert, Eleni Hatzidimitriadou, Andreas Karlsso, Örjan Sundin, Olga Tóth, Ellisabeth Ioannidi-Kapolou, Olivier Degomme, Jorge A. Cervilla, Henrique Barros,
... Alemania (n = 546), Atenas-Grecia (n = 548), Budapest-Hungría (n = 604), Porto-Portugal (n = 635), Granada-España ( ... y Portugal, y en los hombres de Bélgica, Hungría, Portugal y Suecia. Ha habido un exceso de ...
Tópico(s): Child Abuse and Trauma
2013 - Elsevier BV | Gaceta Sanitaria
A. Blanco-Hungría, A Rodriguez-Torronteras, A. Blanco-Aguilera, Lourdes Biedma Velázquez, Rafael Serrano del Rosal, R. Segura-Saint-Gerons, Jimmy de la Torre, F. Esparza-Díaz,
... on average in women than in men Blanco-Hungría A, Rodríguez-Torronteras A, Blanco-Aguilera A, Biedma- ...
Tópico(s): Pain Mechanisms and Treatments
2012 - Medicina Oral S.L. | Medicina oral, patología oral y cirugía bucal
Ricardo Barragán, Ottilia Szives,
... rocas del Aptiano (Cretácico Inferior) de México y Hungría. El presente trabajo incluye descripciones de M. cf. ... de ammonites del Aptiano medio; el material de Hungría proviene de una capa condensada que contiene biota ...
Tópico(s): Marine Biology and Ecology Research
2007 - Elsevier BV | Geobios
Witold Zatoński, Małgorzata Mikucka, Carlo La Vecchia, Peter Boyle,
... de Europa central y del este (República Checa, Hungría, Polonia, Eslovaquia y Eslovenia). Hemos calculado las tasas ... 1.000, hasta 14,8/1.000 en Hungría y 19,4/1.000 en Polonia. Sin ...
Tópico(s): Global Maternal and Child Health
2006 - Elsevier BV | Gaceta Sanitaria
Produção Nacional
Revisado por pares
Marisa Nicolás, Mariangela Hungría, C. A. A. Arias,
... QTLs [Nicolás, M.F., Arias, C.A.A., Hungria, M., 2002. Genetics of nodulation and nitrogen fixation ...
Tópico(s): Nematode management and characterization studies
2005 - Elsevier BV | Field Crops Research
... la primera esquema de permiso prolongado introducido en Hungría en 1967 y los cambios desde el fin ... de ciertas tendencias divergentes, la República Checa y Hungría convergieron hacia el fin de los 90s, como ...
Tópico(s): Intergenerational Family Dynamics and Caregiving
2002 - Taylor & Francis | Community Work & Family
Ján Feranec, Marcel Šúri, Ján Oťaheľ, Tomáš Cebecauer, Jan Kolář, Tomáš Soukup, Dagmar Zdeňková, Jiří Waszmuth, Vasile Vâjdea, Anca-Marina Vîjdea, Constantin Nitica,
... cuatro países pertenecientes a Phare (la República Checa, Hungría, Rumanía, y la República Eslovaca). Se identificaron los ... de monte-chaparral por 26.339 ha. En Hungría, los cambios más pronunciados fueron una disminución de ...
Tópico(s): Land Use and Ecosystem Services
2000 - Elsevier BV | International Journal of Applied Earth Observation and Geoinformation
... zu analysieren, auf denen Magyar Zuzuki und Ford Hungria versuchen, hegemoniale Betriebsordnungen in ihren "im Grünen errichteten" ... auf Widerstand, wa¨hrend die Betriebsleitung bei Ford Hungria Internalisation durch Zustimmung zu erreichen suchte. Der Aufsatz ...
Tópico(s): Urbanization and City Planning
1998 - Routledge | Regional Studies
... visto recientemente una disminucion en su nupcialidad (RDA, Hungria y Yugoslavia). La cohabitacion parece entonces estar lejos, ... por su rapido crecimiento como por nivel alcanzado: Hungria, RDA y Checoslovaquia. En estos la frecuencia de ...
Tópico(s): Geography and Environmental Studies in Latin America
1991 - Institut national d'études démographiques | Population
Saad Z. Usmani, María‐Victoria Mateos, Hareth Nahi, Sebastian Grosicki, Vladimir Vorobyev, Ivan Špıčka, Vânia Hungria, Sibirina Korenkova, Max Flogegård, Joan Bladé, Philippe Moreau, Martin Kaiser, Shinsuke Iida, Jacob P. Laubach, Tara Masterson, Kristen Lantz, Lisa O’Rourke, Christoph Heuck, Xiang Qin, Dolly A. Parasrampuria, Ming Qi, Nizar J. Bahlis,
... Consultancy, Honoraria; Novartis: Consultancy, Honoraria; Celgene: Consultancy, Honoraria. Hungria:Takeda: Consultancy, Honoraria, Membership on an entity's ...
Tópico(s): Synthesis and Biological Evaluation
2019 - Elsevier BV | Blood
... questão do júri no pensamento do penalista Nelson Hungria levando em consideração o contexto histórico das transformações ... a (in)distinção no uso por parte de Hungria dos argumentos do tecnicismo jurídico-penal em relação ...
Tópico(s): Brazilian cultural history and politics
2009 - UNIVERSIDADE EST.PAULISTA JÚLIO DE MESQUITA FILHO | História (São Paulo)
Kenji Kaneko, K. Furuya, Ana B. Hungría, Juan Carlos Hernández‐Garrido, Paul A. Midgley, Tsunenobu Onodera, Hitoshi Kasai, Yusuke Yaguchi, Hidetoshi Oikawa, Yohei Nomura, Hiroki Harada, Tatsumi Ishihara, Norio Baba,
... on: Oxford Academic PubMed Google Scholar Ana B. Hungria, Ana B. Hungria 3Department of Materials Science and Metallurgy, University of ...
Tópico(s): Semiconductor materials and devices
2009 - Oxford University Press | Microscopy
Produção Nacional
Revisado por pares
Raymond L. Comenzo, Giovanni Palladini, Efstathios Kastritis, Monique C. Minnema, Ashutosh D. Wechalekar, Arnaud Jaccard, Angela Dispenzieri, Hans C. Lee, Vaishali Sanchorawala, Simon Gibbs, Peter Mollee, Chris Venner, Jin Lu, Stefan Schönland, Moshe E. Gatt, Kenshi Suzuki, Kihyun Kım, María Teresa Cibeira, Meral Bekşac, Edward N. Libby, Jason Valent, Vânia Hungria, Sandy W. Wong, Michael Rosenzweig, Naresh Bumma, NamPhuong Tran, Xiang Qin, Samer K. Khaled, Jessica Vermeulen, Giampaolo Merlini,
... Bureau; Takeda Pharmaceuticals: Speakers Bureau; Amgen: Speakers Bureau. Hungria: Amgen, BMS, Celgene, Janssen: Honoraria, Membership on an ...
Tópico(s): Drug Transport and Resistance Mechanisms
2021 - Elsevier BV | Blood
Produção Nacional
Revisado por pares
María‐Victoria Mateos, Pieter Sonneveld, Vânia Hungria, Ajay K. Nooka, Jane Estell, Wolney Barreto, Paolo Corradini, Chang‐Ki Min, Eva Medvedova, Katja Weisel, Christopher Chiu, Jordan M. Schecter, Himal Amin, Xiang Qin, Ming Qi, Andrew Spencer,
... BMS: Honoraria, Research Funding; Celgene: Honoraria, Research Funding. Hungria:Amgen: Honoraria; Celgene: Honoraria; Janssen: Honoraria; Takeda: Honoraria. ...
Tópico(s): Multiple Myeloma Research and Treatments
2018 - Elsevier BV | Blood
Produção Nacional
Revisado por pares
María‐Victoria Mateos, Paweł Robak, Marek Hus, Zhongjun Xia, Vera Zherebtsova, Christopher Ward, P. Joy Ho, Roman Hájek, Kihyun Kım, Meletios Α. Dimopoulos, Claudio Cerchione, Antonio Riccio, Astrid McKeown, Rachel Rogers, Hena Baig, Lydia Eccersley, Sumita Roy–Ghanta, Joanna Opalinska, Vânia Hungria,
439572 Background: Belamaf, a BCMA-targeted antibody drug conjugate, has previously demonstrated clinical activity and a manageable safety profile, supporting its use in combination with standard-of-care (SoC) therapies in RRMM. DREAMM-7 (NCT04246047) is a global, randomized, open-label, phase III head-to-head trial evaluating the efficacy and safety of BVd triplet vs SoC triplet, DVd, in patients (pts) with RRMM with ≥1 prior line of therapy (LOT). Methods: Pts with ≥1 prior LOT were randomized (1:1) ...
Tópico(s): Cancer therapeutics and mechanisms
2024 - Lippincott Williams & Wilkins | Journal of Clinical Oncology
Produção Nacional
Revisado por pares
Florent Malard, Paola Neri, Nizar J. Bahlis, Evangelos Terpos, Nour Moukalled, Vânia Hungria, Salomon Manier, Mohamad Mohty,
Tópico(s): Hematopoietic Stem Cell Transplantation
2024 - Nature Portfolio | Nature Reviews Disease Primers
Produção Nacional
Revisado por pares
Vânia Hungria, Paweł Robak, Marek Hus, Vera Zherebtsova, Christopher Ward, P. Joy Ho, Ana Carolina Ribas de Almeida, Roman Hájek, Kihyun Kım, Sebastian Grosicki, Hanlon Sia, Adam Bryant, Marcelo Pitombeira de Lacerda, Gracia Martínez, Anna Maria Sureda Balarí, Irwindeep Sandhu, Claudio Cerchione, Peter Ganly, Meletios Α. Dimopoulos, Chengcheng Fu, Mamta Garg, Al‐Ola Abdallah, Albert Oriol, Moshe E. Gatt, Michèle Cavo, Robert M. Rifkin, Tomoaki Fujisaki, Michał Mielnik, Nick Pirooz, Astrid McKeown, Simon McNamara, Xiangdong Zhou, Maureen Nichols, Eric Lewis, Rachel Rogers, Hena Baig, Lydia Eccersley, Sumita Roy–Ghanta, Joanna Opalińska, María-Victoria Mateos,
Belantamab mafodotin had single-agent activity in patients with relapsed or refractory multiple myeloma, a finding that supports further evaluation of the agent in combination with standard-care therapies.
Tópico(s): Peptidase Inhibition and Analysis
2024 - Massachusetts Medical Society | New England Journal of Medicine
Produção Nacional
Revisado por pares
Meletios Α. Dimopoulos, Vânia Hungria, Atanas Radinoff, Sosana Delimpasi, Gábor Mikala, Tamás Masszi, Li J, Marcelo Capra, Ângelo Maiolino, Vasiliki Pappa, Dominik Chraniuk, Iurii Osipov, Xavier Leleu, Michael Löw, Morio Matsumoto, Neal Sule, Mary Li, Astrid McKeown, Wei He, Shelley Bright, Brooke M. Currie, Sue Perera, Julia Boyle, Sumita Roy–Ghanta, Joanna Opalińska, Katja Weisel,
Multiple myeloma remains incurable, and heavily pretreated patients with relapsed or refractory disease have few good treatment options. Belantamab mafodotin showed promising results in a phase 2 study of patients with relapsed or refractory multiple myeloma at second or later relapse and a manageable adverse event profile. We aimed to assess the safety and efficacy of belantamab mafodotin in a phase 3 setting.In the DREAMM-3 open-label phase 3 study, conducted at 108 sites across 18 countries, ...
Tópico(s): Protein Degradation and Inhibitors
2023 - Elsevier BV | The Lancet Haematology